Last updated 08-09-2026
Category:
Reviews:
Join thousands of AI enthusiasts in the World of AI!
Aionisys
Aionisys Advanced Biosystems builds AI-ready Industrial IoT infrastructure for hospitals that manufacture advanced immunotherapies on site. The platform connects bioprocessing workflows with hospital-side execution so healthcare institutions can run GMP-compliant cell therapy production locally rather than shipping samples to centralized labs. It supports decentralized manufacturing of oncology and other advanced biotherapeutics at the point of care.
Most cell therapy production still happens in distant central facilities, which adds cost and delays for hospital patients. Aionisys focuses on bridging that gap with edge computing, real-time monitoring, and audit-ready data logging built for GMP validation rather than generic factory automation.
Hospital biomanufacturing teams, oncology programs, and healthcare institutions exploring point-of-care advanced therapies are the intended users. Aionisys Advanced Biosystems Ltda lists [email protected] as the contact on its public site, with no self-serve signup or pricing page published.
AI-ready Industrial IoT infrastructure connecting bioprocessing to hospital-side execution
Decentralized control that maintains global GMP standards across local manufacturing nodes
Automated validation and audit-ready data logging for regulatory compliance
Real-time monitoring and edge computing for therapy production workflows
Therapy-agnostic design optimized for oncology and diverse advanced biotherapeutics
Purpose-built for hospital-side GMP manufacturing rather than generic lab software
Therapy-agnostic platform with explicit focus on oncology and advanced biotherapeutics
Includes automated validation, audit-ready logging, and real-time edge monitoring
No public pricing, signup, or product demo on the website
Very limited public documentation beyond a single homepage and privacy policy
What does Aionisys do?
Aionisys Advanced Biosystems provides AI-ready Industrial IoT infrastructure that lets hospitals manage GMP-compliant manufacturing of advanced immunotherapies locally. The platform bridges complex bioprocessing with point-of-care execution through automation and real-time monitoring.
Who is Aionisys built for?
Aionisys targets healthcare institutions that want to produce advanced therapies, including oncology treatments, at the hospital rather than relying solely on centralized labs. Hospital biomanufacturing teams and oncology programs are the primary audience.
Does Aionisys publish pricing online?
No. The Aionisys website does not list plan prices or a public pricing page. Interested hospitals must contact Aionisys directly through [email protected] for commercial details.
How does Aionisys handle GMP compliance?
Aionisys includes automated validation and audit-ready data logging as core platform capabilities. Real-time monitoring and edge computing help hospitals meet regulatory rigor during decentralized manufacturing workflows.
How do you contact Aionisys?
Aionisys lists [email protected] on its homepage as the contact email. The company is registered as Aionisys Advanced Biosystems Ltda, with a privacy policy at aionisys.com/privacy-policy.
What therapies does Aionisys support?
Aionisys describes its platform as therapy agnostic, with optimization for oncology and diverse advanced biotherapeutics. The site specifically mentions enabling local production of innovative cancer treatments alongside other advanced therapies.